This process involved coding the data into recurring themes, including selenium’s antioxidant mechanisms, interaction with selenoproteins, dose-dependent effects, genetic variability in selenium response, and implications for breast cancer treatment and prevention. This evidence concerns the gene SELENOS and breast carcinoma.